Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caribou Biosciences Inc (NQ: CRBU )

8.280 -0.360 (-4.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,253,881
Open 8.760
Bid (Size) 8.000 (2)
Ask (Size) 8.690 (1)
Prev. Close 8.640
Today's Range 7.960 - 9.055
52wk Range 6.410 - 32.65
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap... 
Via Benzinga

Performance

YTD
-45.95%
-45.95%
1 Month
+3.76%
+3.76%
3 Month
-15.08%
-15.08%
6 Month
-56.10%
-56.10%
1 Year
-49.26%
-49.26%

More News

Read More
58 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Caribou's Lymphoma Candidate Shows 100% Response Rate In Early-Stage Study
Via Benzinga
4 Analysts Have This to Say About Caribou Biosciences
Via Benzinga
Caribou Biosciences Earnings Perspective: Return On Capital Employed
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
Via Benzinga
5 Penny Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
2 Penny Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
35 Biggest Movers From Friday
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
28 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2021
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.